Valuation: Krka, d. d.

Market Cap 7.95B 9.12B 7.52B 6.83B 12.77B 874B 12.83B 89.59B 34.64B 444B 34.28B 33.52B 1,422B P/E 2026 *
18.8x
P/E 2027 * 17.9x
Enterprise Value 7.37B 8.47B 6.98B 6.34B 11.85B 811B 11.9B 83.13B 32.14B 412B 31.8B 31.1B 1,319B EV / Sales 2026 *
3.41x
EV / Sales 2027 * 3.17x
Free-Float
74.74%
Yield 2026 *
3.75%
Yield 2027 * 3.94%
1 week+0.57%
Current month-0.19%
1 month+0.96%
3 months-0.57%
6 months+13.15%
Current year+29.31%
1 week 259.5
Extreme 259.5
263
1 month 257.5
Extreme 257.5
267
Current year 202
Extreme 202
270
1 year 174
Extreme 174
270
3 years 104.5
Extreme 104.5
270
5 years 80
Extreme 80
270
10 years 48.01
Extreme 48.01
270
Manager TitleAgeSince
Chief Executive Officer 71 01/01/2005
Director of Finance/CFO - 01/01/2026
Chief Tech/Sci/R&D Officer - 01/03/2023
Director TitleAgeSince
Director/Board Member 59 01/01/2005
Director/Board Member 59 01/01/2005
Director/Board Member 73 01/01/2010
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+0.57%+18.78%+148.82% 9.12B
-1.61%-0.15%+11.45%+60.09% 46.78B
-1.02%-1.90%+35.99%+99.64% 37.88B
+2.19%+3.65%+10.70%+80.29% 11.82B
+1.32%+2.09%-11.64%+12.41% 11.61B
+0.63%+2.31%+29.89%+38.52% 7.38B
+1.30%+1.17%+16.08%+187.41% 7.12B
-0.06%+2.97%+38.90%-18.37% 7.21B
+1.38%-2.74%-42.62%+6.68% 4.99B
+1.80%+0.85%+39.84%+113.77% 4.57B
Average +0.56%+0.53%+14.74%+72.93% 14.85B
Weighted average by Cap. -0.31%+0.01%+17.82%+74.59%

Financials

2026 *2027 *
Net sales 2.16B 2.49B 2.05B 1.86B 3.48B 238B 3.49B 24.4B 9.44B 121B 9.34B 9.13B 387B 2.29B 2.63B 2.17B 1.97B 3.68B 252B 3.7B 25.86B 10B 128B 9.89B 9.67B 410B
Net income 430M 494M 407M 370M 691M 47.32B 695M 4.85B 1.88B 24.05B 1.86B 1.81B 76.98B 455M 522M 430M 391M 730M 49.99B 734M 5.12B 1.98B 25.4B 1.96B 1.92B 81.32B
Net Debt -574M -659M -543M -493M -922M -63.08B -926M -6.47B -2.5B -32.06B -2.47B -2.42B -103B -680M -781M -644M -585M -1.09B -74.79B -1.1B -7.67B -2.96B -38.01B -2.93B -2.87B -122B
Logo Krka, d. d.
Krka dd Novo Mesto is a Slovenia-based company engaged in the production of pharmaceutical preparations. The Company operates through four segments: Prescription Pharmaceuticals that includes medicines for the treatment of cardiovascular diseases, alimentary tract and metabolism and drugs for diseases of the central nervous system, among others; Non-prescription Products, providing vitamins and minerals, cough and cold products, analgesics, sore throat products, among others; Animal Health Products, which offers general anti-infectives and antiparasitics for animals; Health Resort and Tourist Services consisting of Spa resorts in Smarjeske Toplice, Dolenjske Toplice, Strunjan, Novo Mesto and Otocec. Krka dd Novo Mesto is a controlling company of the Krka Group that includes two subsidiaries in Slovenia, Terme Krka doo and Farma GRS doo, and over 20 subsidiaries abroad in such countries as Croatia, Germany, Sweden, Poland, Spain, United States, Ireland, among others.
Employees
13,300
Date Price Change Volume
17/09/26 €262.50 0.00% 4,516
16/09/26 €262.50 +0.96% 5,111
15/09/26 €260.00 -0.95% 4,250
14/09/26 €262.50 +0.96% 1,687
11/09/26 €260.00 -0.38% 4,454
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
262.50EUR
Average target price
257.83EUR
Spread / Average Target
-1.78%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KRKG Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!